n,n-dimethylarginine has been researched along with Amyotrophic Lateral Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguirre, C; Atsuta, N; Baba, K; Hotta, Y; Ikenaka, K; Ito, D; Kakuda, K; Katsuno, M; Kimura, K; Kimura, Y; Maeda, Y; Mochizuki, H; Nagano, S; Sobue, G; Tatebe, H; Tokuda, T; Torii, R; Yamada, S | 1 |
1 other study(ies) available for n,n-dimethylarginine and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Arginine; Biomarkers; Disease Progression; Humans; Nitric Oxide; Prognosis | 2022 |